SlideShare a Scribd company logo
EPIDEMIOLOGICAL
INDICES OF TB
Presented By: Ahamed Faris
EPIDEMIOLOGICAL INDICES
 Indices or Parameters – They are factors needed to measure the TB problems in a community, as well
as to plan and to evaluate control measures.
 Indices are also required for international comparison.
These following epidemiological indices are generally used in TB problem measurement and programme
strategy.
1. INCIDENCE
2. PREVALENCE
3. MORTALITY
4. CARE FATALITY RATE
5.CASE NOTIFICATION RATE
6. CASE DETECTION RATE
7. PREVALENCE OF DRUG-RESISTANT CASES
8. INCIDENCE OF INFECTION
9. PREVALENCE OF INFECTION
1. INCIDENCE
It is defined as number of new and recurrent (relapse) episodes of all forms
of TB occuring in a given year.
Recurrent episodes- defined as new episode of TB in people, who have had TB
in the past and for whom there was bacteriological confirmation of cure or
documentation that treatment was completed.
Relapse cases are referred to add recurrent cases because that term is more
useful in explaining estimation of TB incidence.
Recurrent cases maybe True Relapses or new episode of TB caused by
reinfection
But people with a continuing episode of TB that requires a treatment
change are considered as PREVALENCE, not incident cases.
In current case definitions, both relapse cases and patient who require a
chamge in treatment are considered as “RETREATMENT CASES”.
2. Prevalence
Prevalence is defined as the number of all forms of TB cases at a given
point in time.
It is the best available practical index to estimate the case load in a
community.
Age specific Prevalence – Of patients is considered as the best and most
relevant Index.
3. Mortality
Mortality from TB is defines as number of deaths caused by TB in HIV-
negative people, according to the latest revision of International
Classification of Diseases(ICD-10).
HIV Negative people are considered, because HIV positive people’s
deaths are considered as HIV deaths in (ICD-10).
For this reason, estimate of death in HIV negative people are seperately
measured from those in HIV positive.
It is calculated in unit deaths/lakh population.
4. Case fatality rate
It is defined as risk of death due to TB from people with active TB
disease.
5. Case Notification Rate
It refers to new and recurrent episodes of TB notified to WHO for a
given year., expressed per 1 lakh population.
The case notification rate for new and recurrent TB is important for
estimation of TB incidence.
However, in some countries, information on treatment history maybe
missing in some cases.
Im such condition, recurrent cases cant be distinguished from cases
whose treatment was changed.
Since both are registered and reported in category “RETREATMENT”.
Patients reported in the unknown history category are considered in
incident TB episodes (new or relapse).
6. Case detection Rate
It is calculated as number of notinfication of new and relapse cases in a
year divided by the estimated incidence of such cases in a same year.
7 Prevalence of Drug-Resistant Cases
 It is the prevalence of patients excreting tubercle bacilli resistant to anti-TB drugs.
 This index is directly related to chemotherapy.
 (a) Prevalence Of Infection
 . It is % of individuals who show a postive reaction to the STANDARD TUBERCULIN TEST.
 When the same test is done in defined age-groups, it yields age specific prevalence,which
is a far more superior indicator.
 It must be noted that Tuberculin test interpretation has become much complicated in
countries with high BCG vaccination coverage at birth, because all vaccines become positive
reactors to Tuberculin test.
 This becomes a problem in identifying true prevalence of infection.
 Further cross-sensitivity to an atypical mycobacteria, where it occurred had also caused the
prevalence index to be overestimated.
 Even though these disadvantages, Tuberculin test is widely used for estimating prevalence of
TB infection in a population.
(b) Incidence Of Infection
Also known as annual infection Rate.
It is the % of population under study, who will be infected by M. tuberculosis,
among the non-infected of the preceding survey, during the course of one
year.
It reflects the ANNUAL RISK OF being infected (or reinfected) in a
community.
Simply, it expresses the attacking force of TB pathogen in a community.
Also known as Tuberculin Conversion Index, this parameter is considered one
of the best indicators for evaluating tuberculosis problem and its trend.
Higher the rate, larger is the problem.
In a good treatment programme, lowers the risk of TB infection in a
community
Epidemiological indices   afk

More Related Content

What's hot

EPIDEMIOLOGY OF TUBERCULOSIS
EPIDEMIOLOGY OF TUBERCULOSISEPIDEMIOLOGY OF TUBERCULOSIS
EPIDEMIOLOGY OF TUBERCULOSIS
Santosh Yadav
 
An Update of Lot Quality Assurance Sampling (LQAS) Technologies Valdez
An Update of Lot Quality Assurance Sampling (LQAS) Technologies ValdezAn Update of Lot Quality Assurance Sampling (LQAS) Technologies Valdez
An Update of Lot Quality Assurance Sampling (LQAS) Technologies Valdez
CORE Group
 
applications of epidemiology
applications of epidemiologyapplications of epidemiology
applications of epidemiologySagar Dalal
 
Dengue epidemiology& case management
Dengue epidemiology& case managementDengue epidemiology& case management
Dengue epidemiology& case management
Menaal Kaushal
 
Tuberculosis in india
Tuberculosis in indiaTuberculosis in india
Tuberculosis in india
Sahdev Bishnoi
 
Disease outbreak investigation
Disease outbreak investigationDisease outbreak investigation
Disease outbreak investigation
paddington mundagowa
 
Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute RiskTauseef Jawaid
 
Epidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by whoEpidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by who
Rama shankar
 
Diagnosis of Pulmonary Tuberculosis
Diagnosis of Pulmonary TuberculosisDiagnosis of Pulmonary Tuberculosis
Diagnosis of Pulmonary Tuberculosis
Jack Frost
 
National Vector Borne Disease Control Programme
National Vector Borne Disease Control ProgrammeNational Vector Borne Disease Control Programme
National Vector Borne Disease Control Programme
DrAnup Kumar
 
NVBDCP
NVBDCPNVBDCP
Outbreak investigation
Outbreak investigationOutbreak investigation
Outbreak investigation
Amandeep Kaur
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
ADIL .
 
prevention of malaria
prevention of malariaprevention of malaria
prevention of malaria
Ashwin Gobbur
 
Advanced diagnostics of tuberculosis 21 3-15
Advanced diagnostics of tuberculosis 21 3-15Advanced diagnostics of tuberculosis 21 3-15
Advanced diagnostics of tuberculosis 21 3-15
Yahya Noori, Ph.D
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
Dr Lipilekha Patnaik
 
Global and Indian plan to End TB
Global and Indian plan to End TBGlobal and Indian plan to End TB
Global and Indian plan to End TB
Rama shankar
 
Health information
Health informationHealth information
Health information
Jayaramachandran S
 
Outbreak investigation steps
Outbreak investigation stepsOutbreak investigation steps
Outbreak investigation steps
Abdiwali Abdullahi Abdiwali
 

What's hot (20)

EPIDEMIOLOGY OF TUBERCULOSIS
EPIDEMIOLOGY OF TUBERCULOSISEPIDEMIOLOGY OF TUBERCULOSIS
EPIDEMIOLOGY OF TUBERCULOSIS
 
An Update of Lot Quality Assurance Sampling (LQAS) Technologies Valdez
An Update of Lot Quality Assurance Sampling (LQAS) Technologies ValdezAn Update of Lot Quality Assurance Sampling (LQAS) Technologies Valdez
An Update of Lot Quality Assurance Sampling (LQAS) Technologies Valdez
 
applications of epidemiology
applications of epidemiologyapplications of epidemiology
applications of epidemiology
 
Dengue epidemiology& case management
Dengue epidemiology& case managementDengue epidemiology& case management
Dengue epidemiology& case management
 
Tuberculosis in india
Tuberculosis in indiaTuberculosis in india
Tuberculosis in india
 
Disease outbreak investigation
Disease outbreak investigationDisease outbreak investigation
Disease outbreak investigation
 
Relative and Atribute Risk
Relative and Atribute RiskRelative and Atribute Risk
Relative and Atribute Risk
 
Epidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by whoEpidemiology of tb with recent advances acknowledged by who
Epidemiology of tb with recent advances acknowledged by who
 
Diagnosis of Pulmonary Tuberculosis
Diagnosis of Pulmonary TuberculosisDiagnosis of Pulmonary Tuberculosis
Diagnosis of Pulmonary Tuberculosis
 
Tb control in india
Tb control in indiaTb control in india
Tb control in india
 
National Vector Borne Disease Control Programme
National Vector Borne Disease Control ProgrammeNational Vector Borne Disease Control Programme
National Vector Borne Disease Control Programme
 
NVBDCP
NVBDCPNVBDCP
NVBDCP
 
Outbreak investigation
Outbreak investigationOutbreak investigation
Outbreak investigation
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
 
prevention of malaria
prevention of malariaprevention of malaria
prevention of malaria
 
Advanced diagnostics of tuberculosis 21 3-15
Advanced diagnostics of tuberculosis 21 3-15Advanced diagnostics of tuberculosis 21 3-15
Advanced diagnostics of tuberculosis 21 3-15
 
Epidemic investigation
Epidemic investigationEpidemic investigation
Epidemic investigation
 
Global and Indian plan to End TB
Global and Indian plan to End TBGlobal and Indian plan to End TB
Global and Indian plan to End TB
 
Health information
Health informationHealth information
Health information
 
Outbreak investigation steps
Outbreak investigation stepsOutbreak investigation steps
Outbreak investigation steps
 

Similar to Epidemiological indices afk

Epidemiology
EpidemiologyEpidemiology
Epidemiology
Manoj Godara
 
Pharmacotherapy of Tuberculosis
Pharmacotherapy of TuberculosisPharmacotherapy of Tuberculosis
Pharmacotherapy of Tuberculosis
Koppala RVS Chaitanya
 
Communicable diseases 1
Communicable diseases 1Communicable diseases 1
Communicable diseases 1
Suhail Naqvi
 
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptxLECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
Ivwananjisikombe1
 
TB recurrence in Abbottabad.pptx
TB recurrence in Abbottabad.pptxTB recurrence in Abbottabad.pptx
TB recurrence in Abbottabad.pptx
DrMuhammadZiaUllahSh
 
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
mhosn627
 
The value of real-world evidence for clinicians and clinical researchers in t...
The value of real-world evidence for clinicians and clinical researchers in t...The value of real-world evidence for clinicians and clinical researchers in t...
The value of real-world evidence for clinicians and clinical researchers in t...
Arete-Zoe, LLC
 
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial InfectionIntro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
Philippine Hospital Infection Contol Nurses Associaton (PHICNA) Inc.
 
Mesurement of morbidity (prevalence) presentation
Mesurement of morbidity (prevalence)   presentationMesurement of morbidity (prevalence)   presentation
Mesurement of morbidity (prevalence) presentation
Drsadhana Meena
 
Defing the Epidemiologic of Covid-19
Defing the Epidemiologic of Covid-19Defing the Epidemiologic of Covid-19
Defing the Epidemiologic of Covid-19
Valentina Corona
 
PPT Scarpellini "TB and HIV positive people"
PPT Scarpellini "TB and HIV positive people"PPT Scarpellini "TB and HIV positive people"
PPT Scarpellini "TB and HIV positive people"
StopTb Italia
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
shahriar470
 
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
asclepiuspdfs
 
Bioinformatics in pandemic Script
Bioinformatics in pandemic ScriptBioinformatics in pandemic Script
Bioinformatics in pandemic Script
YOGESHHK
 
Presentation1-2.pptx
Presentation1-2.pptxPresentation1-2.pptx
Presentation1-2.pptx
BarnabasKipngetich
 
OUTBREAK REPORT: INFECTIOUS DISEASE.docx
OUTBREAK REPORT: INFECTIOUS DISEASE.docxOUTBREAK REPORT: INFECTIOUS DISEASE.docx
OUTBREAK REPORT: INFECTIOUS DISEASE.docx
Dr Christa Maria Joel MBBS MPH MRSPH
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiologymlogaraj
 
Management of Acute HIV-1 Infection
Management of Acute HIV-1 InfectionManagement of Acute HIV-1 Infection
Management of Acute HIV-1 InfectionRongpong Plongla
 

Similar to Epidemiological indices afk (20)

Epidemiology
EpidemiologyEpidemiology
Epidemiology
 
Diagnostic_Dossier_December_2014_HE
Diagnostic_Dossier_December_2014_HEDiagnostic_Dossier_December_2014_HE
Diagnostic_Dossier_December_2014_HE
 
Pharmacotherapy of Tuberculosis
Pharmacotherapy of TuberculosisPharmacotherapy of Tuberculosis
Pharmacotherapy of Tuberculosis
 
Communicable diseases 1
Communicable diseases 1Communicable diseases 1
Communicable diseases 1
 
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptxLECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
LECTURE 6 EPIDEMIOLOGICAL CALCULATIONS.pptx
 
TB recurrence in Abbottabad.pptx
TB recurrence in Abbottabad.pptxTB recurrence in Abbottabad.pptx
TB recurrence in Abbottabad.pptx
 
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
 
The value of real-world evidence for clinicians and clinical researchers in t...
The value of real-world evidence for clinicians and clinical researchers in t...The value of real-world evidence for clinicians and clinical researchers in t...
The value of real-world evidence for clinicians and clinical researchers in t...
 
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial InfectionIntro to Infectious Diseases and Epidemiology of Nosocomial Infection
Intro to Infectious Diseases and Epidemiology of Nosocomial Infection
 
Mesurement of morbidity (prevalence) presentation
Mesurement of morbidity (prevalence)   presentationMesurement of morbidity (prevalence)   presentation
Mesurement of morbidity (prevalence) presentation
 
Defing the Epidemiologic of Covid-19
Defing the Epidemiologic of Covid-19Defing the Epidemiologic of Covid-19
Defing the Epidemiologic of Covid-19
 
PPT Scarpellini "TB and HIV positive people"
PPT Scarpellini "TB and HIV positive people"PPT Scarpellini "TB and HIV positive people"
PPT Scarpellini "TB and HIV positive people"
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
 
Bioinformatics in pandemic Script
Bioinformatics in pandemic ScriptBioinformatics in pandemic Script
Bioinformatics in pandemic Script
 
NTEP and recent advances.pptx
NTEP and recent advances.pptxNTEP and recent advances.pptx
NTEP and recent advances.pptx
 
Presentation1-2.pptx
Presentation1-2.pptxPresentation1-2.pptx
Presentation1-2.pptx
 
OUTBREAK REPORT: INFECTIOUS DISEASE.docx
OUTBREAK REPORT: INFECTIOUS DISEASE.docxOUTBREAK REPORT: INFECTIOUS DISEASE.docx
OUTBREAK REPORT: INFECTIOUS DISEASE.docx
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 
Management of Acute HIV-1 Infection
Management of Acute HIV-1 InfectionManagement of Acute HIV-1 Infection
Management of Acute HIV-1 Infection
 

Recently uploaded

Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 

Recently uploaded (20)

Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 

Epidemiological indices afk

  • 2. EPIDEMIOLOGICAL INDICES  Indices or Parameters – They are factors needed to measure the TB problems in a community, as well as to plan and to evaluate control measures.  Indices are also required for international comparison. These following epidemiological indices are generally used in TB problem measurement and programme strategy. 1. INCIDENCE 2. PREVALENCE 3. MORTALITY 4. CARE FATALITY RATE 5.CASE NOTIFICATION RATE 6. CASE DETECTION RATE 7. PREVALENCE OF DRUG-RESISTANT CASES 8. INCIDENCE OF INFECTION 9. PREVALENCE OF INFECTION
  • 3. 1. INCIDENCE It is defined as number of new and recurrent (relapse) episodes of all forms of TB occuring in a given year. Recurrent episodes- defined as new episode of TB in people, who have had TB in the past and for whom there was bacteriological confirmation of cure or documentation that treatment was completed. Relapse cases are referred to add recurrent cases because that term is more useful in explaining estimation of TB incidence. Recurrent cases maybe True Relapses or new episode of TB caused by reinfection But people with a continuing episode of TB that requires a treatment change are considered as PREVALENCE, not incident cases. In current case definitions, both relapse cases and patient who require a chamge in treatment are considered as “RETREATMENT CASES”.
  • 4. 2. Prevalence Prevalence is defined as the number of all forms of TB cases at a given point in time. It is the best available practical index to estimate the case load in a community. Age specific Prevalence – Of patients is considered as the best and most relevant Index.
  • 5. 3. Mortality Mortality from TB is defines as number of deaths caused by TB in HIV- negative people, according to the latest revision of International Classification of Diseases(ICD-10). HIV Negative people are considered, because HIV positive people’s deaths are considered as HIV deaths in (ICD-10). For this reason, estimate of death in HIV negative people are seperately measured from those in HIV positive. It is calculated in unit deaths/lakh population.
  • 6. 4. Case fatality rate It is defined as risk of death due to TB from people with active TB disease.
  • 7. 5. Case Notification Rate It refers to new and recurrent episodes of TB notified to WHO for a given year., expressed per 1 lakh population. The case notification rate for new and recurrent TB is important for estimation of TB incidence. However, in some countries, information on treatment history maybe missing in some cases. Im such condition, recurrent cases cant be distinguished from cases whose treatment was changed. Since both are registered and reported in category “RETREATMENT”. Patients reported in the unknown history category are considered in incident TB episodes (new or relapse).
  • 8. 6. Case detection Rate It is calculated as number of notinfication of new and relapse cases in a year divided by the estimated incidence of such cases in a same year.
  • 9. 7 Prevalence of Drug-Resistant Cases  It is the prevalence of patients excreting tubercle bacilli resistant to anti-TB drugs.  This index is directly related to chemotherapy.  (a) Prevalence Of Infection  . It is % of individuals who show a postive reaction to the STANDARD TUBERCULIN TEST.  When the same test is done in defined age-groups, it yields age specific prevalence,which is a far more superior indicator.  It must be noted that Tuberculin test interpretation has become much complicated in countries with high BCG vaccination coverage at birth, because all vaccines become positive reactors to Tuberculin test.  This becomes a problem in identifying true prevalence of infection.  Further cross-sensitivity to an atypical mycobacteria, where it occurred had also caused the prevalence index to be overestimated.  Even though these disadvantages, Tuberculin test is widely used for estimating prevalence of TB infection in a population.
  • 10. (b) Incidence Of Infection Also known as annual infection Rate. It is the % of population under study, who will be infected by M. tuberculosis, among the non-infected of the preceding survey, during the course of one year. It reflects the ANNUAL RISK OF being infected (or reinfected) in a community. Simply, it expresses the attacking force of TB pathogen in a community. Also known as Tuberculin Conversion Index, this parameter is considered one of the best indicators for evaluating tuberculosis problem and its trend. Higher the rate, larger is the problem. In a good treatment programme, lowers the risk of TB infection in a community